Atara Biotherapeutics Inc (NASDAQ:ATRA)

8.30
Delayed Data
As of Jul 01
 +0.51 / +6.55%
Today’s Change
4.61
Today|||52-Week Range
20.04
-47.34%
Year-to-Date
No recent news for Atara Biotherapeutics Inc.

Today’s Trading

Previous close7.79
Today’s open7.79
Day’s range7.73 - 8.38
Volume1,324,402
Average volume (3 months)1,149,773
Market cap$774.3M
Data as of 3:59pm ET, 07/01/2022

Growth & Valuation

Earnings growth (last year)+12.39%
Earnings growth (this year)+9.21%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales72.58
Price/Book2.72

Competitors

----
COGTCogent Biosciences I...+0.37+4.10%
SRNESorrento Therapeutic...+0.14+6.97%
MORFMorphic Holding Inc+0.53+2.44%
Data as of 4:00pm ET, 07/01/2022

Financials

Next reporting dateAugust 8, 2022
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$20.3M
Annual profit (last year)-$340.1M
Net profit margin-1,672.28%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts